Global Glucose Biosensor Market by Product & Data Validation, Analysis and Forecast 2022
ReportsWeb.com published “Glucose Biosensor Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, January 09, 2017 ) According to Publisher, the Global Glucose Biosensor Market is accounted for $15.3 billion in 2015 and is expected to reach $30.5 billion by 2022 growing at a CAGR of 10.29% from 2015 to 2022. Growing demand for expansion of technologically advanced products and non-invasive products are some of the primary factors favouring the market growth. Furthermore, increasing frequency of diabetes across the globe, need for early diabetes detection and patient awareness levels are some of the drivers fuelling the market growth. However, high cost, reluctance towards the adoption of the new treatment practices and slow rate of commercialization are the restraints limiting the market growth. The recent trends in Glucose Biosensors market are increasing adoption of the POC diagnostic kits and wearable healthcare devices.
Fluorescence segment is expected to capture the largest market share over the forecast period. North America is expected to witness highest growth rate in terms of value and share. High disease burden and the subsequent need to curb associated healthcare expenditure in the U.S. is attributing to the favorable North American market.
For more information http://www.reportsweb.com/glucose-biosensor-global-market-outlook-2015-2022
Some of the key players in the market include Roche Diagnostics, LifeScan Inc., Abbott Laboratories, Bayer, Medtronic Inc., Pinnacle Medical Solutions Inc., AgaMatrix Inc., Sanofi S.A., BioSense Medical Devices, LLC, Nova Biomedical, Lifesensors, Inc., Animas Corporation, Siemens Healthcare Diagnostics, Inc., F. Hoffman-La Roche and M-Biotech Limited.
End User Covered:
- Hospitals
- Homecare Diagnostics
- Other end users
Type Covered:
- Amprometric Glucose Biosensors
- Fluorescence Glucose Biosensors
- Other types
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216389/sample
9 Company Profiling
9.1 Roche Diagnostics
9.2 LifeScan Inc.
9.3 Abbott Laboratories
9.4 Bayer
9.5 Medtronic Inc.
9.6 Pinnacle Medical Solutions Inc.
9.7 AgaMatrix Inc.
9.9 Sanofi S.A.
9.9 BioSense Medical Devices, LLC
9.10 Nova Biomedical
9.11 Lifesensors, Inc.
9.12 Animas Corporation
9.13 Siemens Healthcare Diagnostics, Inc.
9.14 F. Hoffman-La Roche
9.15 M-Biotech Limited
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216389/buying
Fluorescence segment is expected to capture the largest market share over the forecast period. North America is expected to witness highest growth rate in terms of value and share. High disease burden and the subsequent need to curb associated healthcare expenditure in the U.S. is attributing to the favorable North American market.
For more information http://www.reportsweb.com/glucose-biosensor-global-market-outlook-2015-2022
Some of the key players in the market include Roche Diagnostics, LifeScan Inc., Abbott Laboratories, Bayer, Medtronic Inc., Pinnacle Medical Solutions Inc., AgaMatrix Inc., Sanofi S.A., BioSense Medical Devices, LLC, Nova Biomedical, Lifesensors, Inc., Animas Corporation, Siemens Healthcare Diagnostics, Inc., F. Hoffman-La Roche and M-Biotech Limited.
End User Covered:
- Hospitals
- Homecare Diagnostics
- Other end users
Type Covered:
- Amprometric Glucose Biosensors
- Fluorescence Glucose Biosensors
- Other types
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216389/sample
9 Company Profiling
9.1 Roche Diagnostics
9.2 LifeScan Inc.
9.3 Abbott Laboratories
9.4 Bayer
9.5 Medtronic Inc.
9.6 Pinnacle Medical Solutions Inc.
9.7 AgaMatrix Inc.
9.9 Sanofi S.A.
9.9 BioSense Medical Devices, LLC
9.10 Nova Biomedical
9.11 Lifesensors, Inc.
9.12 Animas Corporation
9.13 Siemens Healthcare Diagnostics, Inc.
9.14 F. Hoffman-La Roche
9.15 M-Biotech Limited
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216389/buying
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results